Dirk Schürmann

4.9k total citations
115 papers, 2.8k citations indexed

About

Dirk Schürmann is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Dirk Schürmann has authored 115 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Infectious Diseases, 36 papers in Epidemiology and 25 papers in Virology. Recurrent topics in Dirk Schürmann's work include HIV/AIDS drug development and treatment (26 papers), HIV Research and Treatment (22 papers) and Nuclear physics research studies (20 papers). Dirk Schürmann is often cited by papers focused on HIV/AIDS drug development and treatment (26 papers), HIV Research and Treatment (22 papers) and Nuclear physics research studies (20 papers). Dirk Schürmann collaborates with scholars based in Germany, Italy and United States. Dirk Schürmann's co-authors include B. Ruf, Petra Reinke, Thomas Berg, H. D. Pohle, Stefan Mauss, Thomas Wünsche, Bertram Wiedenmann, A Bergk, Florian van Bömmel and F. J. Fehrenbach and has published in prestigious journals such as Physical Review Letters, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

Dirk Schürmann

112 papers receiving 2.7k citations

Peers

Countries citing papers authored by Dirk Schürmann

Since Specialization

Citations

This map shows the geographic impact of Dirk Schürmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk Schürmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk Schürmann more than expected).

Fields of papers citing papers by Dirk Schürmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dirk Schürmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk Schürmann. The network helps show where Dirk Schürmann may publish in the future.

Co-authorship network of co-authors of Dirk Schürmann

This figure shows the co-authorship network connecting the top 25 collaborators of Dirk Schürmann. A scholar is included among the top collaborators of Dirk Schürmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dirk Schürmann. Dirk Schürmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Stage‐adapted treatment of HIV‐associated Hodgkin lymphoma: Long‐term results of a prospective, multicenter study 2024 ·HemaSphere ·Marcus Hentrich, Markus Müller, Christoph Wyen, (unknown), Vindi Jurinović, Jan Siehl, Jürgen K. Rockstroh, Dirk Schürmann, (unknown), (unknown)	1
2	AIDS in the era of antiretroviral therapy: Changes in incidence rates and predictors of AIDS among people living with HIV under clinical care in Germany, a cohort study 1999–2018 2023 ·HIV Medicine ·(unknown), Christian Kollan, Barbara Gunsenheimer‐Bartmeyer, Björn‐Erik Ole Jensen, Christoph Stephan, Olaf Degen, Dirk Schürmann, Tobias Kurth, Viviane Bremer, Uwe Koppe, (unknown)	0
3	Mycobacterium tuberculosis-specific CD4 T-cell scoring discriminates tuberculosis infection from disease 2022 ·European Respiratory Journal ·(unknown), Tim Meyer, Mariana Schürmann, (unknown), Harald Bias, David J. Krieger, Torsten Bauer, Petra Bächer, Johannes Helmuth, Hans‐Dieter Volk, Dirk Schürmann, Alexander Scheffold, Christian Meisel	5
4	Monkeypox in-patients with severe anal pain 2022 ·Infection ·Frieder Pfäfflin, Daniel Wendisch, Roland Scherer, Linda Jürgens, (unknown), (unknown), Pinkus Tober‐Lau, Miriam Stegemann, Victor M. Corman, Florian Kurth, Dirk Schürmann	42
5	Treatment of a giant hepatic echinococcal cyst with percutaneous drainage and in vivo assessment of the protoscolicidal effect of praziquantel 2021 ·Clinical Journal of Gastroenterology ·Joachim Richter, Andreas K. Lindner, Dominik Geisel, Giovanni Torsello, Gabriela E. Martínez, (unknown), Dirk Schürmann, Frieder Pfäfflin, (unknown), Tommaso Manciulli, Enrico Brunetti	8
6	High-dose glucocorticoid treatment of near-fatal bocavirus lung infection results in rapid recovery 2021 ·ERJ Open Research ·(unknown), Oliver Schildgen, Dirk Schürmann, (unknown), Martin Janz, Ulrich Keller, Bernhard Gebauer, Johannes Schilling, Stefan Schwartz, Benedikt Weißbrich, Thomas Schneider, Jörg Hofmann, Stephan Mathas	1
7	Measurement of 1323 and 1487 keV resonances inN15(α,γ)F19with the recoil separator ERNA 2017 ·Physical review. C ·A. Di Leva, G. Imbriani, R. Buompane, L. Gialanella, A. Best, S. Cristallo, M. De Cesare, Antonio D’Onofrio, (unknown), L. R. Gasques, L. Morales-Gallegos, Alessandro Pezzella, (unknown), D. Rapagnani, V. Roca, M. Romoli, Dirk Schürmann, O. Straniero, F. Terrasi	18
8	Strict bed rest after EBV implant reduces pneumothorax rate 2014 ·European Respiratory Journal ·(unknown), Stefan Hippenstiel, Dirk Schürmann, (unknown), Alexander Pöllinger, Bettina Temmesfeld‐Wollbrück, Norbert Suttorp, Ralf‐Harto Hübner	1
9	Prevalence of interlobar collateral ventilation in COPD patients 2014 ·European Respiratory Journal ·(unknown), Stefan Hippenstiel, Dirk Schürmann, (unknown), Alexander Pöllinger, Bettina Temmesfeld‐Wollbrück, Norbert Suttorp, Ralf‐Harto Hübner	2
10	Toxoplasmic encephalitis in AIDS-patients before and after the introduction of highly active antiretroviral therapy (HAART) 2011 ·European Journal of Clinical Microbiology & Infectious Diseases ·(unknown), Oliver Liesenfeld, Dirk Schürmann, Thomas Schneider	17
11	Combination of tenofovir and lamivudine versus tenofovir after lamivudine failure for therapy of hepatitis B in HIV-coinfection 2006 ·AIDS ·Guenther Schmutz, Mark Nelson, Thomas A. Lutz, Julie Sheldon, Raffaele Bruno, (unknown), Christian Hoffmann, Juergen Rockstroh, Albrecht Stoehr, Eva Wolf, Vincent Soriano, F. Berger, Thomas Berg, Amina Carlebach, Carolynne Schwarze‐Zander, Dirk Schürmann, Hans Jaeger, Stefan Mauss	66
12	Highly active antiretroviral therapy (HAART) improves survival in HIV-associated Hodgkin's disease: results of a multicenter study 2006 ·Annals of Oncology ·Marcus Hentrich, (unknown), Kai Uwe Chow, Johannes R. Bogner, Dirk Schürmann, (unknown), (unknown), D. Reichelt, M. Vogel, Markus Ruhnke, Mark Oette, (unknown), Jürgen K. Rockstroh, Keikawus Arastéh, (unknown)	38
13	Interleukin-2: A Potential Treatment Option for Postherpetic Neuralgia? 2006 ·Clinical Infectious Diseases ·(unknown), L. M. Heinzerling, Dirk Schürmann, Norbert Suttorp	7
14	Detektion von Atemwegsstenosen: Vergleich der virtuellen mit der flexiblen Bronchoskopie 2005 ·RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren ·Rainer Röttgen, Dirk Schürmann, Jens Pinkernelle, H. Herzog, (unknown), (unknown), M. Lorenz, (unknown), R. Félix, R Schröder	4
15	Comparison of Adefovir and Tenofovir in the Treatment of Lamivudine–Resistant Hepatitis B Virus Infection 2004 ·Hepatology ·Florian van Bömmel, Thomas Wünsche, Stefan Mauss, Petra Reinke, A Bergk, Dirk Schürmann, Bertram Wiedenmann, Thomas Berg	293
16	Twice-weekly Pyrimethamine–sulfadoxine Effectively Prevents Pneumocystis carinii Pneumonia Relapse and Toxoplasmic Encephalitis in Patients with AIDS 2001 ·Journal of Infection ·Dirk Schürmann, Frank Bergmann, Helmut Albrecht, Jan-Sören Padberg, Thomas Grünewald, (unknown), Martin P. Grobusch, Marc Vallée, Thomas Wünsche, B. Ruf, Norbert Suttorp	16
17	Tuberculosis and HIV infection: A review 1997 ·Infection ·Dirk Schürmann, Stephen D. Nightingale, Frank Bergmann, B. Ruf	6
18	Intensive treatment of AIDS‐related non‐Hodgkin's lymphomas with the MACOP‐B protocol 1995 ·European Journal Of Haematology ·Dirk Schürmann, Thomas Grünewald, (unknown), G. Jautzke, H. D. Pohle, B. Ruf	9
19	Mycobacteremia in AIDS patients 1989 ·Journal of Molecular Medicine ·B. Ruf, Dirk Schürmann, W Brehmer, H. Mauch, H. D. Pohle	7
20	Immunosuppression and mycobacteria other thanMycobacterium tuberculosis: results from patients with and without HIV infection 1989 ·Epidemiology and Infection ·(unknown), Dirk Schürmann, Agnes Mayr, Roland Hetzer, H. D. Pohle, B. Ruf	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact